Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

704 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EZH2 mutations are frequent and represent an early event in follicular lymphoma.
Bödör C, Grossmann V, Popov N, Okosun J, O'Riain C, Tan K, Marzec J, Araf S, Wang J, Lee AM, Clear A, Montoto S, Matthews J, Iqbal S, Rajnai H, Rosenwald A, Ott G, Campo E, Rimsza LM, Smeland EB, Chan WC, Braziel RM, Staudt LM, Wright G, Lister TA, Elemento O, Hills R, Gribben JG, Chelala C, Matolcsy A, Kohlmann A, Haferlach T, Gascoyne RD, Fitzgibbon J. Bödör C, et al. Among authors: haferlach t. Blood. 2013 Oct 31;122(18):3165-8. doi: 10.1182/blood-2013-04-496893. Epub 2013 Sep 19. Blood. 2013. PMID: 24052547 Free PMC article.
Gene expression profiling in sarcomas.
Tschoep K, Kohlmann A, Schlemmer M, Haferlach T, Issels RD. Tschoep K, et al. Among authors: haferlach t. Crit Rev Oncol Hematol. 2007 Aug;63(2):111-24. doi: 10.1016/j.critrevonc.2007.04.001. Epub 2007 Jun 6. Crit Rev Oncol Hematol. 2007. PMID: 17555981 Review.
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features.
Haferlach C, Mecucci C, Schnittger S, Kohlmann A, Mancini M, Cuneo A, Testoni N, Rege-Cambrin G, Santucci A, Vignetti M, Fazi P, Martelli MP, Haferlach T, Falini B. Haferlach C, et al. Among authors: haferlach t. Blood. 2009 Oct 1;114(14):3024-32. doi: 10.1182/blood-2009-01-197871. Epub 2009 May 8. Blood. 2009. PMID: 19429869 Free article.
Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome.
Mills KI, Kohlmann A, Williams PM, Wieczorek L, Liu WM, Li R, Wei W, Bowen DT, Loeffler H, Hernandez JM, Hofmann WK, Haferlach T. Mills KI, et al. Among authors: haferlach t. Blood. 2009 Jul 30;114(5):1063-72. doi: 10.1182/blood-2008-10-187203. Epub 2009 May 14. Blood. 2009. PMID: 19443663 Free article.
Gene expression profiling in acute myeloid leukaemia (AML).
Bacher U, Kohlmann A, Haferlach C, Haferlach T. Bacher U, et al. Among authors: haferlach t, haferlach c. Best Pract Res Clin Haematol. 2009 Jun;22(2):169-80. doi: 10.1016/j.beha.2009.04.003. Best Pract Res Clin Haematol. 2009. PMID: 19698926 Review.
SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations.
Nowak D, Ogawa S, Müschen M, Kato M, Kawamata N, Meixel A, Nowak V, Kim HS, Kang S, Paquette R, Chang MS, Thoennissen NH, Mossner M, Hofmann WK, Kohlmann A, Weiss T, Haferlach T, Haferlach C, Koeffler HP. Nowak D, et al. Among authors: haferlach t, haferlach c. Blood. 2010 Feb 4;115(5):1049-53. doi: 10.1182/blood-2009-03-210377. Epub 2009 Dec 2. Blood. 2010. PMID: 19965645 Free PMC article.
704 results